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ntegrins coordinate spatial signaling events essential for
cell polarity and directed migration. Such signals from 
 
 
 
4
integrins regulate cell migration in development and in
 
leukocyte trafﬁcking. Here, we report that efﬁcient 
 
 
 
4-
mediated migration requires spatial control of 
 
 
 
4 phosphory-
lation by protein kinase A, and hence localized inhibition
of binding of the signaling adaptor, paxillin, to the integrin.
In migrating cells, phosphorylated 
 
 
 
4 accumulated along the
leading edge. Blocking 
 
 
 
4 phosphorylation by mutagenesis
or by inhibition of protein kinase A drastically reduced 
 
 
 
4-
Î
 
dependent migration and lamellipodial stability. 
 
 
 
4 phos-
phorylation blocks paxillin binding in vitro; we now ﬁnd
that paxillin and phospho-
 
 
 
4 were in distinct clusters at the
leading edge of migrating cells, whereas unphosphorylated
 
 
 
4 and paxillin colocalized along the lateral edges of those
cells. Furthermore, enforced paxillin association with 
 
 
 
4
inhibits migration and reduced lamellipodial stability.
These results show that topographically speciﬁc integrin
phosphorylation can control cell migration and polarization
by spatial segregation of adaptor protein binding.
 
Introduction
 
Cell migration is essential for all stages of development, for
wound healing, and immune responses. For a cell to migrate,
a precisely coordinated series of biochemical and physical
events must be regulated in time and space. A migrating
cell polarizes and extends forward processes (lamellipodia
and filopodia), which must then attach to the substratum.
Movement occurs when the cell–ECM connections at the
front of the cell exert tension on the cell body through
transmembrane linkages to the cytoskeleton, concurrent
with a release of cell–ECM attachments at the rear of the
cell (Lauffenburger and Horwitz, 1996). These localized
morphological events are coordinated by spatially restricted
biochemical signals. For example, proteins involved in reg-
ulating actin assembly and lamellipodial protrusions, such
as WASP, profilin, the Arp 2/3 complex, the small GTPase
Rac and its effector PAK, localize to the leading edge in
nascent protrusions in migrating cells (for review see Webb
et al., 2002).
Integrins, receptors which mediate cell–ECM attach-
ments, also initiate and coordinate biochemical signaling
pathways required for cell migration. Integrin signals maintain
the polarity of migrating cells, although the precise bio-
chemical mechanisms that account for this function are
unclear (Lauffenburger and Horwitz, 1996). Phosphorylation
of integrin cytoplasmic tails can modulate binding of accessory
proteins (Tapley et al., 1989; Baker et al., 1997; Cowan et
al., 2000; Han et al., 2001) and thus, influence the signaling
activities of these receptors (Zhang et al., 2001); however,
the topographic distribution of integrin phosphorylation has
not been assessed during cell migration.
The 
 
 
 
4 subfamily of integrins (
 
 
 
4
 
 
 
1 and 
 
 
 
4
 
 
 
7) is of par-
ticular interest in regards cell migration. These integrins are
expressed on leukocytes, neural crest cells, and developing
skeletal muscle, and are essential for embryogenesis, hemato-
poiesis, and immune responses (Hemler, 1990; Yang et al.,
1995; Arroyo et al., 1996). Furthermore, these integrins are
promising therapeutic targets in a wide variety of chronic
inflammatory diseases (von Andrian and Engelhardt, 2003;
 
Rose et al., 2002). The 
 
 
 
4 integrin subunit dramatically
enhances cell migration in comparison with other integrin 
 
 
 
subunits (Chan et al., 1992; Kassner et al., 1995). Thus, we
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reasoned that an understanding of how 
 
 
 
4 integrins pro-
mote cell migration could provide insight into the integrin-
dependent signaling events that control migration.
The capacity of 
 
 
 
4 integrins to enhance cell migration is
a function of the 
 
 
 
4 cytoplasmic tail (Chan et al., 1992).
The 
 
 
 
4 tail binds tightly to paxillin, a cytoplasmic adaptor
protein, and paxillin binding is required for the ability of
 
 
 
4 to enhance migration (Liu and Ginsberg, 2000; Liu et
al., 1999). Furthermore, phosphorylation of Ser
 
988
 
 in the
 
 
 
4 tail inhibits association of paxillin with the 
 
 
 
4 tail in
vitro and in vivo (Han et al., 2001). Because efficient cell
migration requires control of integrin-dependent signaling
functions, we hypothesized that phosphorylation of the 
 
 
 
4
tail may be a regulator of 
 
 
 
4-dependent cell migration. To
address this hypothesis, we generated mAbs specific for 
 
 
 
4
phosphorylated at Ser
 
988
 
, and localized phospho-
 
 
 
4 and
paxillin in migrating cells. In addition, we used a combina-
tion of pharmacological and mutational analyses to evalu-
ate the role of phosphorylation-dependent regulation of
paxillin–
 
 
 
4 association in cell polarization and migration.
Here, we report that efficient 
 
 
 
4-mediated cell migration
requires precise spatial control of 
 
 
 
4 phosphorylation by
protein kinase A (PKA), and hence, of paxillin binding to
the 
 
 
 
4 integrin tail. The spatial regulation of paxillin–
 
 
 
4
interaction contributes to suppression of lamellipodia at
the sides and rear, but not at the leading edge of migrating
cells, and thus, to more efficient cell migration. Thus, we
have defined a topographically specific integrin phosphory-
lation, identified the relevant kinase, and established the
biochemical basis by which the phosphorylation event con-
trols cell migration. Furthermore, we provide direct evi-
dence that paxillin recruitment to 
 
 
 
4 integrins can de-sta-
bilize lamellipodia.
 
Results
 
Phosphorylated 
 
 
 
4 integrin is preferentially localized 
to the leading edge of migrating cells
 
To evaluate the role of 
 
 
 
4 phosphorylation in cell migration,
we first sought to localize phosphorylated 
 
 
 
4 integrin in mi-
grating cells. To do this we generated mAbs specific for an 
 
 
 
4
cytoplasmic domain phosphorylated at Ser
 
988
 
. This phospho-
specific antibody, designated 
 
 
 
-PS
 
 
 
4, reacted with the phos-
phorylated but not unphosphorylated 
 
 
 
4 integrin tail, dem-
onstrating that 
 
 
 
-PS
 
 
 
4 reacts specifically with 
 
 
 
4 when it is
phosphorylated (Fig. 1 A). The antibody was also 
 
 
 
4-specific,
because it reacted with the 150-kD 
 
 
 
4 integrin polypeptide
in Jurkat cells, and failed to react with lysates of JB4 cells, an
 
 
 
4-deficient Jurkat variant cell line (Fig. 1 B). Specificity was
also confirmed by Western blotting 
 
 
 
4 immunoprecipitates
Figure 1. Characterization of a phospho-specific  -PS 4 mAb. 
(A) The  4 integrin–cytoplasmic tail recombinant proteins were 
incubated with protein kinase A (PKA) in the presence of [ 
32P]ATP. 
The autoradiograph in the top panel shows that the  4 tail is 
efficiently phosphorylated by PKA. Only PKA-phosphorylated  4 
tail protein shows reactivity with the  -PS 4 mAb. Coomassie 
stained gels are shown to indicate equal loading of  4 tail proteins. 
(B) Western blot of cell extracts prepared from Jurkat cells and JB4 
cells, an  4-deficient Jurkat variant cell line, indicating specific 
reactivity of the  -PS 4 antibody with endogenous  4 integrin. 
(C)  4 integrins were immunoprecipitated from stably transfected 
CHO cells that had been surface labeled with biotin before lysis for 
detection of  4 protein using avidin-HRP.  -PS 4 antibody reacts 
with immunoprecipitated wt  4, but does not recognize  4 containing 
a Ser
988 to Ala mutation.
Figure 2.  4 integrin is preferentially phosphorylated at the leading 
edge of migrating cells. (a–c) CHO cells expressing human  4 
integrin were plated onto dishes coated with 2  g/ml CS-1 ( 4 1-
binding) fragment of fibronectin and scratch wounded. The 
localization of the phosphorylated  4 was assessed by staining with 
 -PS 4. Serine phosphorylated  4 is localized to clusters at the 
leading edges of polarized cells, and in the perinuclear region. 
(d) Primary human peripheral blood monocytes migrating on CS-1 
show leading edge localization of phosphorylated endogenous 
 4. Bar, 25  m. (e) A7r5 rat smooth muscle cells were plated on 
fibronectin on 3- m porous filters by the method of Cho and Klemke 
(2002). Pseudopodia (Pd) and cell bodies (CB) were isolated, lysed 
and  4 was immunoprecipitated with HP2/1 mAb for  4. Immuno-
precipitates were blotted with  -PS 4, then stripped and reprobed 
with a rabbit polyclonal antibody (Rb038) raised against  4. 
Phosphorylated  4 integrin is highly enriched in leading pseudopodia 
in polarized cells.T
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with 
 
 
 
-PS
 
 
 
4. 
 
 
 
-PS
 
 
 
4 reacted with a 150-kD polypeptide in
 
 
 
4 immunoprecipitates from cells expressing wild-type 
 
 4,
but not  4 in which Ser
988 has been mutated to a nonphos-
phorylatable Ala (Fig. 1 C). Thus, this mAb is both  4 se-
quence specific and phosphorylation specific.
We used  -PS 4 to assess the distribution of phosphory-
lated  4 in migrating cells. We examined CHO cells express-
ing recombinant  4, and used scratch wound assays to in-
duce polarized migration. Scratch wounds were made in
confluent cultures plated on coverslips coated with the CS-1
fragment of fibronectin (CS-1), an  4-specific ligand. The
phosphorylated   4 was present predominantly along the
leading edge of polarized cells migrating into the wound
space (Fig. 2, a–c), but was consistently absent at the lateral
and trailing edges (Fig. 2, a–c). Phosphorylated  4 was also
localized to the leading edge of polarized primary human
monocytes migrating on CS-1 toward a chemoattractant gra-
dient of stromal-derived factor-1 (Fig. 2 d), indicating that
the polarization of  4 phosphorylation occurs with the native
protein at natural abundance. A perinuclear pool of phospho-
 4 was also noted in both cell types. In confluent cell cul-
tures, phospho- 4 staining was limited to the perinuclear re-
gions, with no detectable antibody reactivity at cell borders
(unpublished data). To provide further confirmation that  4
phosphorylation is up-regulated in the leading edge of polar-
ized cells, we isolated pseudopodia and cell bodies from  4-
expressing smooth muscle cells. Although  4 integrin was
present in cell bodies and pseudopodia, phosphorylated  4
was specifically enriched in the pseudopodia (Fig. 2 e). Thus,
membrane-associated phosphorylated  4 is enriched at the
leading edge of migrating cells.
Blockade of  4 phosphorylation inhibits lamellipodial 
extension during cell migration
The distinct localization of phospho- 4 at the leading edge
of migrating cells suggested that  4 phosphorylation might
be involved in the ability of cells to migrate on  4 integrin
ligands. To test this idea, we examined the effect of mutat-
ing the serine phosphorylation site to alanine ( 4(S988A)),
a mutation that eliminates phosphorylation of the  4 tail
(Han et al., 2001). Confluent CHO cells expressing
 4(S988A) or wild-type  4 were plated on CS-1 and scratch
wounded. The closure of the wound was quantified by phase
microscopy as a measure of directed cell migration. The cells
expressing  4(S988A) failed to extend lamellipodia into the
wound and showed markedly reduced migration and wound
closure relative to cells expressing wild-type  4 (Fig. 3).
Both cell types express similar levels of  4 integrins at the
cell surface, adhered to a similar extent to CS-1, and bound
similar amounts of soluble VCAM-1, an activation-specific
ligand (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200304031/DC1; and not depicted). Thus, the mi-
gratory defect in the S988A mutant was not due to a loss of
adhesion or a reduction in  4 affinity.
To further confirm the specificity of staining with the
 -PS 4 antibody, both cell types were fixed and stained
with antibodies to  4 (HP2/1) and phospho- 4. Whereas
both cell types showed strong staining for  4, only cells ex-
pressing wild-type  4, but not  4(S988A), showed reactiv-
ity with the  -PS 4 antibody (Fig. 3 B). Notably, the peri-
nuclear staining was also absent in the cells expressing
 4(S988A). Thus, a mutation that precludes phosphoryla-
tion of  4 blocks lamellipodial extension and cell migration.
The  4(S988A) mutation blocked lamellipodial extension
and migration in a scratch wound assay. To obtain additional
insight into the mechanism of this effect, we examined the ef-
fect of this mutation on the random migration and edge dy-
namics of cells using real time video microscopy. Cells ex-
pressing this mutant ruffled and extended protrusions in
various directions from the cell body; however, the protru-
sions rapidly collapsed and the cells failed to stably polarize
and migrate (migration rate   4.3  m/h   0.58; Fig. 4;
Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200304031/DC1). In sharp contrast, cells expressing
wild-type  4 developed stable leading lamellipodia and ex-
hibited clear directional migration (migration rate   14.7
 m/h    1.06; Fig. 4; and Video 2, available at http://
www.jcb.org/cgi/content/full/jcb.200304031/DC1). Lamel-
lipodial extensions in wild-type  4 cells persisted for an aver-
age of 3.4 min   0.28, with 65   3.3% of lamellipodia last-
ing  3 min. In contrast, cells expressing  4(S988A) extended
protrusions that persisted for an average of 1.1 min   0.36,
with 91   0.8% of protrusions collapsing after 1 min (Fig.
4). Thus, the  4(S988A) mutation interfered with the ability
of the cells to develop stable polarized lamellipodia.
PKA is a kinase that phosphorylates  4 Ser
988 (Han et al.,
2001). Therefore, we used pharmacological inhibition of
PKA activity as an alternative approach to evaluate the role
of  4 phosphorylation in  4-dependent cell migration. We
examined the effect of Rp-cAMP, an inhibitor of PKA activ-
ity, on  4 phosphorylation (Gjertsen et al., 1995). Cells
were fixed and stained with  -PS 4 to detect the distribu-
tion of phosphorylated  4. Inhibition of PKA activity abro-
gated phospho- 4 staining at the leading edge membrane
Figure 3. The phosphorylation-resistant  4(S988A) mutation inhibits 
 4-dependent cell migration. (A) CHO cells stably expressing wt  4 
or  4(S988A) were plated onto dishes coated with 2  g/ml CS-1, 
scratch wounded at confluence, and allowed to migrate into the 
wound space for 16 h. The ratio of the final wound area to the area 
immediately after scratching is indicated as percent closure. The 
cells bearing  4(S988A) manifest drastically reduced  4-dependent 
migration. (B) CHO cells expressing  4wt (a and b) or  4(S988A) 
cells (c and d) were fixed 16 h after scratch wounding and stained 
with antibodies to  4 (a and c) or with  -PS 4 (b and d).  4 is localized 
around the cell periphery, but is phosphorylated only at the leading 
edge.  -PS 4 does not react with CHO cells bearing  4(S988A). 
Bar, 25  m.T
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Figure 4.  4 phosphorylation is required for cell polarization, lamellipodial stabilization, and directed migration. (A) CHO cells bearing 
 4 wt,  4(S988A), or  4 fused to paxillin, plated on dishes coated with 2  g/ml CS-1, were observed in random migration assays by phase-
contrast microscopy and photographed every 10 min for 4 h. Representative cells are shown at times 0, 60, 120, and 180 min. Persistence 
tracks indicate displacements of cell centroids over 240 min. CHO cells bearing  4 polarize, extend lamellipodia and migrate in the direction 
of the lamellipodium. Those bearing  4(S988A) or an  4-paxillin chimera do not polarize and do not migrate. (B) Migration rates are shown T
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(Fig. 5 A). Interestingly, inhibition of PKA did not abolish a
perinuclear pool of phospho- 4 staining. However, this
staining was phospho- 4 specific, as it was not seen in cells
transfected with  4(S988A) (Fig. 3 B). We observed the
same loss of leading edge phospho- 4 staining in cells incu-
bated with another specific inhibitor of PKA, H-89 (Fig. 5
A). To confirm that PKA activity is required for promoting
increased levels of phosphorylated  4 in cells, lysates from
scratch-wounded and confluent cultures were subjected to
Western blotting with the  -PS 4 antibody. Phosphory-
lated  4 levels in scratch-wounded cultures increased rela-
tive to confluent cultures (Fig. 5 C). Furthermore, incuba-
tion of scratch-wounded cells with H-89 markedly reduced
the total level of phosphorylated  4 in scratch wounds.
However, inhibition of PKA had no effect on the levels of
phosphorylated  4 in unwounded, confluent cultures (Fig.
5 C), indicating that PKA activity is required for the increase
of  4 phosphorylation that follows wounding.
The ablation of phospho- 4 staining at the leading edge
of migrating cells by inhibition of PKA activity blocked the
 4-dependent migration of CHO 4 cells (Fig. 5 B). In con-
trast, such treatment had no effect on the already reduced
migration of cells expressing  4(S988A) (unpublished data).
Inhibition of cell migration by Rp-cAMP is  4 specific, as
treatment of CHO 4 cells did not reduce the migration of
these cells on an  5 1 ligand, the central cell binding do-
main of Fn (Fig. 5 B). Thus, inhibition of  4 phosphoryla-
tion blocks  4 1 integrin–dependent cell migration.
Phospho- 4 and paxillin are localized in distinct 
regions in migrating cells
The foregoing experiments showed that phosphorylated  4
is enriched at the leading edge of migrating cells, and this  4
phosphorylation is required for optimal polarization, lamel-
lipodial stabilization, and migration of cells on an  4 ligand.
Because  4 phosphorylation inhibits the binding of paxillin
to the  4 cytoplasmic domain, we hypothesized that the role
of  4 phosphorylation in cell migration is to reverse the pax-
illin– 4 association. Therefore, we stained migrating cells
for paxillin and either total  4 or phospho- 4, and moni-
tored basal localization in 0.1- m thick basal confocal sec-
tions. Paxillin was observed in focal complexes in migrating
and nonmigrating cells (Fig. 6; and Fig. S2, available at http:
//www.jcb.org/cgi/content/full/jcb.200304031/DC1). In
migrating cells, paxillin consistently localized in clusters
throughout the basal cell surface, including at the leading
edge, and also in streaks along the lateral edges. Total  4
colocalized with paxillin staining along lateral edges (Fig. 6
and Fig. S2). However, no phospho- 4 staining could be
detected along lateral edges of migrating cells, sites where
paxillin was present (Fig. 6 and Fig. S2). At the leading edge,
paxillin localized to focal complexes adjacent to, but not co-
based on cell centroid assignments for at least 40 cells/trial, n   3. Migration rates in the right panel indicate average cell displacement 
between successive time points. CHO cells bearing  4wt exhibit persistent, high migration rates over 4 h, whereas cells bearing  4(S988A) 
or an  4-paxillin chimera maintain significantly lower migration rates over the experimental time frame. (C) The number and persistence of 
protrusions was tracked by phase-contrast microscopy. CHO 4wt and CHO 4(S988A) cells plated on CS-1 were photographed every minute 
for 10 min, and protrusions were scored visually in successive images (n   10 cells for each cell type). (B and C) Error bars represent SEM for 
all cells counted.
Figure 5. Inhibition of PKA activity 
blocks  4 phosphorylation at the leading 
edge and  4-dependent migration. 
(A) CHO cells bearing  4 were plated 
on dishes coated with 2  g/ml CS-1 and 
confluent monolayers were scratch 
wounded, and incubated with 100  M 
Rp-cAMP (b), 30  M H-89 (c), or without 
inhibitors (a) for 30 min, and then fixed 
and stained with  -PS 4. Rp-cAMP or 
H-89 treatment eliminates phosphory-
lation of  4 at the leading edge. (B) CHO 
cells bearing  4 were plated on dishes coated with 2  g/ml 
CS-1 ( 4 1) or 3Fn(9-11) ( 5 1) and confluent monolayers 
were scratch wounded, and incubated with or without 
Rp-cAMP at 37 C for 16 h. Migration into the wound was 
assessed as described in Materials and methods. Treatment 
with Rp-cAMP inhibits migration on CS-1, but has no effect 
on migration on the  5 integrin–binding 3Fn(9–11) fragment 
of fibronectin. Error bars are the SD from the average width 
of the wound space measured in three independent trials.
(C) CHO 4wt and CHO 4(S988A) cells were plated on CS-1, 
allowed to reach confluence, and either left unscratched, or 
scratch wounded with multiple scratches in a grid pattern. 
Wounded and unwounded cultures were incubated for 30 min 
in the presence or absence of 30  M H89, and then extracted 
in lysis buffer. Lysates were adjusted to identical protein 
concentrations and analyzed by SDS-PAGE followed by 
Western blotting with  -PS 4.T
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incident with, clusters of phospho- 4. These focal com-
plexes also did not contain  1 integrins, as evidenced by
double staining with antibodies to  1 integrin and paxillin
(unpublished data). Conversely, no phospho- 4 was de-
tected in paxillin-rich clusters at the leading edge (Fig. 6 and
Fig. S2). These staining patterns were observed both in cells
that had migrated out from the monolayer (Fig. 6), as well as
in polarized cells at the leading edge of the monolayer (Fig.
S2). Colocalization of paxillin with phospho- 4 staining or
with total  4 staining in migrating cells was also assessed
morphometrically, for 200 cells in each case. 61   1.6% of
total  4 staining colocalized with paxillin in migrating cells,
versus 11   1.4% colocalization for phospho- 4 and paxil-
lin (Fig. 6). Thus, phospho- 4 and paxillin do not colocal-
ize along the leading edge of migrating cells, whereas non-
phosphorylated   4 and paxillin do colocalize along the
lateral and trailing edges.
To confirm that the observed colocalization of paxillin
and  4 is dependent on the absence of  4 phosphoryla-
tion, we costained CHO cells expressing  4(S988A) or
 4(S988D)—a phospho-mimicking mutant which in-
hibits paxillin binding to the  4 tail (Han et al., 2001)—
with antibodies to  4 and paxillin. CHO cells bearing
 4(S988A) remained rounded and did not spread (Figs. 3
and 7), and in these cells paxillin was observed in clusters
throughout the basal cell surface, and concentrated around
the cell perimeter.  4 staining colocalized with paxillin
around the edges of these cells, but was not seen in the pax-
illin-rich central clusters (Fig. 7). In contrast, CHO cells
bearing the pseudo-phosphorylation mutant,  4(S988D),
showed pronounced spreading, and in these cells  4 was lo-
calized in clusters across the basal cell surface, and did not
show appreciable colocalization with the paxillin-rich clus-
ters (Fig. 7). Thus, nonphosphorylated  4 colocalizes with
paxillin, whereas phosphorylated or pseudo-phosphorylated
 4 fails to do so.
Figure 6. Paxillin colocalizes with 
nonphosphorylated  4 at the lateral and 
trailing edges but not with phospho- 4 
at the leading edge. CHO cells expressing 
 4wt were plated on CS-1, scratch 
wounded and stained with antibodies 
to paxillin (a) and total  4 (b), or paxillin 
(c) and phospho- 4 (d). Images shown 
are confocal micrographs of 0.1- m basal 
sections. Cells that are separated from 
the monolayer are shown in a through d to 
demonstrate colocalization of paxillin 
(red) with total  4 (green) at the lateral 
and trailing edges. Colocalization maps 
are shown in e and f. Yellow pseudocolor 
indicates overlap of red and green 
fluorescence. Percent colocalization 
in the indicated regions is shown in g. 
(h) Percent colocalization between 
paxillin and phospho- 4 or total  4 
staining across the whole cell area, in 200 
cells analyzed per case (t test   1.15   
10
 8 significance). (g and h) Error bars 
represent SEM of colocalization of red 
and green per pixel. Bar, 25  m.
Figure 7. Colocalization of unphosphorylated  4 with paxillin. 
CHO cells stably expressing nonphosphorylatable  4(S988A) 
(a and c) or pseudo-phosphorylated  4(S988D) (b and d) were 
plated on CS-1 and scratch wounded. The cells were fixed and 
stained with antibodies to paxillin (red) and  4 (green). In a and c, 
the cells remain rounded. Paxillin and  4 are coclustered around 
the cell perimeters, and paxillin is also found in  4-deficient clusters 
at the basal surface. In (b and d), CHO cells expressing  4(S988D) 
are spread, and paxillin is localized in clusters throughout the basal 
surface and at the perimeter. However,  4(S988D) staining shows 
widespread basal localization but virtually no colocalization with 
paxillin. Bar, 25  m.
Enforced association of  4 and paxillin inhibits 
 4-dependent migration
The preceding experiments confirmed that  4 phosphory-
lation prevents its association with paxillin, supporting theT
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hypothesis that  4 phosphorylation is required for cell mi-
gration because it inhibits the paxillin– 4 association. To
directly test this hypothesis, we enforced paxillin association
with the  4 tail by covalently fusing paxillin to the  4
COOH terminus. The  4-paxillin fusion protein becomes
phosphorylated at Ser
988 (Fig. 8 B), indicating that fusing
paxillin to the COOH terminus of the  4 tail does not dis-
rupt   4 phosphorylation. Furthermore, paxillin staining
colocalized with  4 staining around cell perimeters when
these cells were plated on CS-1, confirming that the chi-
mera did enforce the  4-paxillin association. Endogenous
paxillin was also present at the basal cell surface in clusters
which did not contain  4 (Fig. 8 C). Two independent
clones of cells expressing  4 integrin fused at its intracellu-
lar COOH terminus to paxillin migrated poorly on CS-1,
consistent with the hypothesis that constitutive direct bind-
ing of paxillin to  4 integrin inhibits  4-dependent migra-
tion (Fig. 8 A). Joining a 25-kD affinity tag to the COOH
terminus of  4 had no effect on  4-dependent cell migra-
tion (unpublished data), indicating that the effect of the
paxillin fusion was specific. In random migration assays,
cells expressing the  4-paxillin chimera formed ruffles
and extended protrusions (Video S3, available at http://
www.jcb.org/cgi/content/full/jcb.200304031/DC1). How-
ever, similar to CHO 4(S988A) cells, the protrusions
quickly collapsed, the cells failed to stably polarize, and they
did not migrate (migration rate   2.5  m/h   0.30; Fig. 4
and Video 3).
Discussion
 4 integrins strongly promote cell migration through their
interaction with paxillin. We now find that efficient  4-medi-
ated cell migration requires precise spatio-temporal regula-
tion of paxillin binding to the  4 tail specified by topo-
graphically localized PKA-mediated  4 phosphorylation.
First, staining of migrating cells with phospho-specific anti-
 4 antibodies showed that phosphorylated  4 integrin accu-
mulates along the leading edge of migrating cells. Second,
blockade of  4 phosphorylation by substitution of Ser
988
with a nonphosphorylatable Ala led to drastically reduced
 4-dependent cell migration by inhibiting lamellipodial ex-
tension at the leading edge. Third, inhibition of PKA
blocked both  4 phosphorylation at the leading edge and
 4-dependent cell migration. Fourth,  4 phosphorylation
blocks paxillin binding in vitro; we now find that paxillin is
excluded from areas of clustered phospho- 4 at the leading
edge of migrating cells, whereas paxillin colocalizes with
nonphosphorylated  4 along the lateral edges of those cells.
Finally,  4 phosphorylation is required for efficient cell mi-
gration because it blocks paxillin binding to the  4 tail. En-
forced paxillin association with  4 inhibits migration in a
Figure 8. Enforced association of paxillin with 
 4 integrin inhibits migration. (A) CHO cells 
expressing  4 or an  4-paxillin chimera, were 
plated onto dishes coated with 2  g/ml CS-1, scratch 
wounded at confluence, and allowed to migrate 
into the wound space for 16 h. The ratio of the final 
wound area to the area immediately after scratching 
is indicated as percent closure. Direct paxillin fusion 
to  4 integrin drastically reduces  4-dependent 
migration. Error bars are the SD from the average 
width of the wound space measured in three 
independent trials. (B)  4 integrins were immuno-
precipitated from stably transfected CHO cells 
that had been surface labeled with membrane-
impermeable biotin before lysis. Surface  4 was 
detected by staining immunoblots with avidin-
HRP, and phospho- 4 was detected by staining 
with  -PS 4. The antibody reacts with immuno-
precipitated  4 and the  4-paxillin chimera but 
not  4(S988A). (C)  4-paxillin chimera–transfected 
CHO cells were plated on CS-1, allowed to spread, 
and fixed and stained for  4 (a, green) and paxillin 
(b, red); the indicated region is shown as overlay in 
(c). Paxillin colocalizes with  4 at the cell periphery, 
but is also present in clusters across the basal surface 
that do not contain  4. Bar, 25  m.T
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similar fashion to the  4(S988A) nonphosphorylatable mu-
tation; it markedly reduces the stability of lamellipodia.
These results show that efficient  4-mediated cell migration
requires precise spatial control of  4 phosphorylation, and
hence, of paxillin binding to  4 integrin. The spatial regula-
tion of paxillin– 4 interaction contributes to suppression of
lamellipodia at the sides and rear, but not at the leading edge
of migrating cells, and thus, to more efficient cell migration.
The phosphorylated form of  4 integrin is preferentially
localized along the leading edge of migrating cells and this lo-
calization is required for optimal cell migration. This conclu-
sion is based on the strong staining of phosphorylated  4 at
the leading edge of cells. Importantly, total  4 staining
showed no such preferential localization and phosphorylated
 4 was enriched in isolated pseudopodia from migrating
smooth muscle cells. Thus, a path length artifact does not ac-
count for the increased phospho- 4 staining at the leading
edge. Furthermore, pharmacologic or mutagenic blockade of
 4 phosphorylation inhibited cell migration. Because cells
expressing  4 containing a nonphosphorylatable  4(S988A)
mutation were unable to extend stable lamellipodia, it is
likely that  4 phosphorylation is important for stable lamelli-
podial protrusion. Conversely, the absence of  4 phosphory-
lation along the lateral edges of polarized, migrating cells was
also required for optimal cell migration because pharmaco-
logically enforced phosphorylation or a phosphorylation-
mimicking  4 mutant also blocks migration in Jurkat T cells
(unpublished data) and in CHO cells (unpublished data).
How is  4 phosphorylation localized to the leading edge?
PKA phosphorylates  4 in vitro at a consensus PKA phos-
phorylation site (Han et al., 2001) and inhibition of PKA
blocked  4 phosphorylation at the leading edge. Thus, se-
lective localization of PKA could lead to preferential local-
ization of phospho- 4 to the leading edge. Indeed, Howe
has reported biochemical evidence for the enrichment of ac-
tive PKA in the leading pseudopodia of migrating cells (un-
published data). This is a site at which integrins are engag-
ing ligands, and engagement of  1 integrins can activate
PKA (O’Connor and Mercurio, 2001). Furthermore, the
greatest protrusive forces are exerted at the leading edge, and
such forces can lead to PKA activation (He and Grinnell,
1994; Ihlemann et al., 1999). Alternatively, we noted an in-
tracellular perinuclear pool of phospho- 4, presumably lo-
calized in vesicles. Insertion of membrane vesicles occurs at
the front of migrating cells (Nabi, 1999); such vesicles could
deliver phospho- 4 to this site. However, inhibition of PKA
did not lead to de-phosphorylation of the internal pool of
 4, but blocked the appearance of phospho- 4 at the lead-
ing edge. Furthermore, PKA inhibition specifically reduced
the levels of phosphorylated  4 in scratch-wounded cells,
but not in unwounded, confluent cultures. These results
suggest that in response to scratch wounding, PKA phos-
phorylates  4 at the front of migrating cells. The mainte-
nance of a phosphorylated internal pool of  4 in the face of
inhibition of PKA may be because the internal  4 is phos-
phorylated by kinases other than PKA or is inaccessible to
de-phosphorylation by phosphatases. In any case, the data
presented here reveal that topographically localized PKA-
mediated  4 phosphorylation is required for efficient  4-
mediated cell migration.
The spatial patterning of  4 phosphorylation contributes
to cell migration by regulating paxillin binding. We previ-
ously showed that PKA-mediated phosphorylation of  4 at
Ser
988 inhibits binding of paxillin to  4 integrins in vitro
(Han et al., 2001). Here, we report that, at the leading edge,
phosphorylated  4 is not colocalized with paxillin, indicat-
ing that  4 phosphorylation disrupts paxillin binding to  4
in vivo. Pinco et al. (2002) have also noted the lack of colo-
calization of  4 and paxillin in the leading edge of migrating
cells. However, at the lateral edges, where the  4 is not
phosphorylated, there was strong colocalization of  4 and
paxillin. Consequently,  4 phosphorylation is likely to be
required to prevent the  4-paxillin association at the ante-
rior of the cell. Indeed, enforced association of paxillin with
the  4 tail leads to the similar inhibition of migration ob-
served in the  4(S988A) mutant. The enforced association
of paxillin with  4 did not impair  4 phosphorylation, indi-
cating that irreversible paxillin association inhibits migration
even when  4 can become phosphorylated. Conversely,  4
phosphorylation or a phosphorylation-mimetic Asp substi-
tution at Ser
988 blocks paxillin binding (Han et al., 2001)
and prevents colocalization of paxillin with  4 in cells. Pax-
illin binding to  4 is required for efficient migration and
when  4 phosphorylation is not localized, it inhibits migra-
tion (unpublished data). Thus, de-phosphorylation of  4 at
the lateral edge of cells is required for both paxillin associa-
tion and resulting optimal migration. Consequently, the
spatial regulation of  4 phosphorylation controls the topo-
graphic localization of paxillin binding to  4, leading to en-
hanced cell migration.
Enforced association of paxillin with the  4 tail may block
formation of stable lamellipodia by interfering with signaling
by the small GTPase, Rac. Rac initiates lamellipodia by pro-
moting Arp2/3-dependent actin polymerization via Scar/
WAVE (Eden et al., 2002). Therefore, a reduction in Rac ac-
tivation could provide a biochemical explanation for the ef-
fects of enforced  4-paxillin association on cell spreading and
on lamellipodial extension. Rac activation is preferentially lo-
calized in the leading edge of migrating cells (Kraynov et al.,
2000) and in pseudopodia (Cho and Klemke, 2002), and
paxillin binds many potential regulators of Rac activation in-
cluding the ARF-GAP p95PKL (Turner et al., 1999), PTP-
PEST (Sastry et al., 2002), and Csk (Sabe et al., 1994). In-
deed, West et al. (2001) showed that displacement of paxillin
from adhesion sites by a  LD4 mutant leads to persistent
lamellipodia and enhanced Rac activation. Thus,  4 phos-
phorylation at the front prevents paxillin binding and, there-
fore, could permit Rac activation and lamellipodial exten-
sion. Conversely, efficient cell migration requires suppression
of lamellipodia at the sides and rear of cells. In these regions,
the binding of paxillin to dephosphorylated  4 could inhibit
Rac activation, thus, suppressing lamellipodia, thereby pro-
moting migration.
Phosphorylation of several integrin cytoplasmic domains
can contribute to cell migration; however, the present stud-
ies now define the importance of regional control of inte-
grin phosphorylation and show how the phosphorylation
controls a specific protein–protein interaction, thereby spa-
tially defining the signaling capacity of the integrin. Previ-
ous studies identified a role for PKC-mediated phosphory-T
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lation of the  3 tail in cell motility (Zhang et al., 2001),
but did not define the biochemical consequences of that
phosphorylation. On the other hand, interaction of the in-
termediate filament cytoskeletal adaptor protein IFAP300/
plectin with  6 4 integrins in epithelial cells is negatively
regulated by serine phosphorylation of the  6 subunit, pos-
sibly mediated by PKC  (Baker et al., 1997; Alt et al.,
2001). Furthermore,   tail tyrosine phosphorylation at
conserved NPxY motifs can regulate the binding of talin
(Tapley et al., 1989; Pfaff et al., 1998; Calderwood et al.,
1999) or Shc (Cowan et al., 2000) and is important in cell
migration (Sakai et al., 2001). However, the relationships
of effects on Shc and talin binding to migration have not
been established.
The present results permit us to propose a scheme to ex-
plain the importance of  4 phosphorylation in integrin-
mediated directional migration.  4 integrin is expressed
around the perimeter of cells, but is selectively phosphory-
lated by PKA at the leading edge. Phosphorylation nega-
tively regulates paxillin binding, so that paxillin is bound to
 4 integrin along the sides of the cell, not at the leading
edge. Binding of paxillin to  4 leads to localized inhibition
of lamellipodia at the sides and rear of the cell. At the lead-
ing edge,  4 phosphorylation displaces paxillin, permitting
formation and stabilization of the lamellipodium in the di-
rection of migration. Consequently, efficient  4-mediated
cell migration requires spatio-temporal regulation of paxil-
lin– 4 interaction by  4 phosphorylation to maintain posi-
tion-specific lamellipodial extension at the leading edge.
Materials and methods
Antibodies and reagents
HP2/1 anti- 4 mAb was purchased from Immunotech. Antipaxillin anti-
body (clone 349) was purchased from Transduction Laboratories. Rb038
rabbit polyclonal antibodies raised against the cytoplasmic tail of  4 have
been described previously (Han et al., 2001). Purification of the human
CS-1 region of fibronectin fused to GST has been described previously
(Jongewaard et al., 1996), using cDNA which was provided by J.W. Smith
(Burnham Institute, La Jolla, CA). cDNA encoding the 3Fn(9–11) fibronec-
tin fragment was a gift from J.W. Ramos (Rutgers University, New
Brunswick, NJ) and was purified as described previously (Ramos and De-
Simone, 1996). Soluble VCAM-1-human IgG1 heavy chain fusion protein
(Jakubowski et al., 1995) was generated from cDNA as described previ-
ously (Rose et al., 2000) at the National Cell Culture Center.
Construction of  4–COOH-terminal fusions
For construction of a mammalian expression vector (pCDNA3; Invitrogen)
encoding an  4-paxillin chimera, pCDNA3.1( ) 4 was modified replac-
ing the stop codon with a KpnI site, GTGGGC encoding Val-Gly). KpnI-
XbaI fragment of full-length human paxillin   was subcloned into the mod-
ified pCDNA3.1( ) 4 resulting in a Val-Gly spacer between the COOH
terminus of  4 and the NH2 terminus of paxillin. For construction of an  4-
TAP fusion, the stop codon in a full-length  4 construct (American Type
Culture Collection) in pcDNA3.1( ) was deleted by PCR mutagenesis and
replaced with a KpnI-NcoI fragment containing a 3-Gly spacer at the
COOH terminus. A 500-bp NcoI-EcoRV fragment containing the complete
TAP tag (Rigaut et al., 1999) was removed from a cDNA provided by Ber-
trand Séraphin (European Molecular Biology Laboratory, Heidelberg, Ger-
many) and inserted into the corresponding sites in the mutant  4 construct.
Generation of phospho-specific anti- 4 mAb
The peptide RDS
988WSYINSK was synthesized with or without phos-
phorylation at Ser
988. Both peptides were purified by reversed-phase
HPLC and their sequences were confirmed by mass spectrometry. The
synthetic peptide (RDS
988WSYINSK with phosphorylation at Ser
988) was
coupled to keyhole limpet hemocyanin with glutaraldehyde as the cou-
pling reagent and injected into mice. Splenocytes were isolated and fused
and individual hybridoma clones were screened by immunoblotting. The
specificity of the monoclonal anti–phospho- 4 was established by ELISA
and then by immunoblotting and immunofluorescence as described in
Results. The mAbs were purified by protein G affinity chromatography
from tissue culture supernatants.
Cell culture and transfection
CHO cells and A7r5 rat smooth muscle cells (American Type Culture Col-
lection) were maintained in DME supplemented with 10% FBS, 2 mM
L-glutamine, 50 U/ml penicillin, 50  g/ml streptomycin sulfate, and 1%
nonessential amino acids. Cells were transfected using LipofectAMINE re-
agent (Invitrogen) following the manufacturer’s instructions, and selected
in DME containing the appropriate antibiotic at 500  g/ml. Single cell sort-
ing for CHO 4 transfectants was performed on HP2/1-labeled cells at the
Scripps Research Institute Cell Sorting Facility. Expression was confirmed
by flow cytometry on FACScan
® (Becton Dickinson), and cells were main-
tained in DME with 250  g/ml selective antibiotic.
In vitro phosphorylation of integrin  4 and Western blotting
Integrin tail mimic proteins were generated and purified as described pre-
viously (Pfaff et al., 1998; Liu et al., 1999). For in vitro phosphorylation as-
says, 1  g of recombinant tail model proteins bound to nickel agarose was
incubated with purified recombinant PKA (Sigma-Aldrich; 50  g total pro-
tein) in kinase buffer (20 mM Hepes, pH 7.0, 2 mM MgCl2, 40  M ATP, 2
 g/ml aprotinin, 40  g/ml bestatin, 0.5  g/ml leupeptin, 0.7  g/ml pepsta-
tin, 0.5 mM Pefabloc, 20 mM glycerophosphate, 50  M sodium vanadate,
1 mM NaF, and 10 mM p-nitrophenol phosphate) containing  -[
32P]ATP
(6,000 Ci/mmol) for 20 min at 30 C. The bead-bound recombinant tail
was washed several times with kinase buffer without ATP, boiled in SDS-
PAGE sample buffer, and resolved by 4–20% SDS-PAGE under reducing
conditions. 
32P-Labeled recombinant tail mimic proteins were visualized
after autoradiography. For Western blotting, protein samples were sepa-
rated by SDS-PAGE and processed by the method of Laemmli (1970).
Membranes were incubated with either primary antibody followed by goat
anti–mouse HRP conjugate (Biosource International), or biotinylated pro-
teins were detected by Vectastain (Vector Laboratories). Labeled proteins
were detected using Supersignal chemiluminescent substrate (Pierce
Chemical Co.).
Monocyte isolation
Monocytes were isolated from human peripheral blood obtained from
healthy adult donors from the Scripps Clinic (La Jolla, CA). Whole blood
containing anticoagulant was centrifuged and the buffy coat was trans-
ferred to a fresh container, and washed three times in PBS( ), without
Ca
2  or Mg
2 . Mononuclear cells were isolated by Ficoll-Hypaque gradi-
ent centrifugation (Amersham Pharmacia Biotech) and washed three times
in PBS( ). Monocytes were isolated by plating washed cells in tissue cul-
ture flasks for 1 h at 37 C. Adherent cells were preserved and maintained
in RPMI 1640, supplemented with 10% FBS, 2 mM L-glutamine, 50 U/ml
penicillin, 50  g/ml streptomycin sulfate, and 1% nonessential amino ac-
ids. Monocytes were later suspended with trypsin/EDTA, replated on ECM-
coated glass coverslips in tissue culture wells, and stimulated with 15 ng/
ml stromal cell-derived growth factor–1  (R&D Systems) in a modified
Dunn chamber (Zicha et al., 2003). Cells were washed, fixed, and pro-
cessed for immunocytochemistry as described in the next paragraph.
Immunocytochemistry
Sterile glass coverslips were coated with ECM proteins (CS-1 and 3Fn(9–
11) fragments of fibronectin) at 2–10  g/ml overnight at 4 C, then blocked
for 1 h with 1 mg/ml BSA. Cells were suspended with trypsin/EDTA and
plated onto coated coverslips and treated as described below in Scratch
wound and random migration assays. Cells were fixed for 5 min in 3.7%
formaldehyde (Sigma-Aldrich) in TBS (0.1 M Tris-HCl, pH 7.4, and 150
mM NaCl) at room temperature, in some cases containing phosphatase in-
hibitors: 20 mM  -glycerophosphate, 50  M sodium vanadate, and 1 mM
NaF. Cells were permeabilized in 0.1% Triton X-100 in TBS containing
phosphatase inhibitors, for 3 min at room temperature. Fixed, permeabi-
lized cultures were blocked with 1 mg/ml BSA for 1 h at 37 C. Coverslips
were labeled with appropriate antibodies for 1 h at 37 C in the presence of
normal goat serum. Coverslips were washed in TBS, and goat anti–mouse
IgG FITC conjugate (Biosource International) or goat anti–rabbit IgG
rhodamine conjugate (Santa Cruz Biotechnology, Inc.) were added at 5
 g/ml and 20  g/ml, respectively, for an additional 45 min at 37 C. Cells
were washed and mounted onto glass slides with Immuno Floure mount-
ing medium (ICN Biomedicals). Cells were viewed on a confocal micro-T
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scope (model MRC 1024; Bio-Rad Laboratories) and images were captured
and analyzed using Lasersharp (Bio-Rad Laboratories) and ImageProPlus
(Media Cybernetics) software applications. Percent colocalization was cal-
culated as the ratio of pixels containing both red and green color above a
threshold level to the total number of red and green pixels over the thresh-
old level in a defined area.
Pseudopod purification
Pseudopod purification was performed as described previously (Cho and
Klemke, 2002). In brief, serum-starved cells were trypsinized and allowed
to attach and spread for 2 h on FN-coated, 3- m pore polycarbonate
membranes in Costar Transwell inserts. 10 ng/ml PDGF-BB chemoattrac-
tant (Upstate Biotechnology) was added to the lower chamber and cells
were allowed to extend processes through the membrane for 1 h. Inserts
were rapidly washed in PBS, cell bodies were removed from the upper sur-
face with cotton swabs, and pseudopodia on the underside were scraped
into lysis buffer (50 mM Tris, pH 7.4, 5 mM EDTA, 150 mM NaCl, phos-
phatase and protease inhibitors [Boehringer], and 1% Triton X-100). Alter-
natively, pseudopodia were removed with cotton swabs and cell bodies on
the upper surface were scraped into lysis buffer. Lysates were clarified by
centrifugation (16,110 g for 15 min at 4 C) and equal amounts of soluble
protein (determined by BCA assay; Pierce Chemical Co.) were used for im-
munoprecipitation.
Scratch wound and random migration assays
Tissue culture dishes (Falcon) or glass coverslips were coated with 2  g/ml
GST-CS-1 or GST-9–11 overnight at 4 C. For scratch wound assays, cells
were suspended with trypsin/EDTA and plated onto coated dishes at a den-
sity of 10
6 cells/35-mm dish. After 2 h, cell cultures were scratched with a
single pass of a pipet tip, and incubated at 37 C for various times. In some
cases, cultures media was supplemented with either 100  M cAMP, Rp-iso-
mer TEA (Calbiochem) or 30  M H-89 (BIOMOL Research Laboratories,
Inc.). Cultures were washed twice with PBS and fixed in 3.7% formalde-
hyde for 10 min. Fixed cultures were either viewed on a phase-contrast mi-
croscope (model IX70; Olympus) and photographed with a camera (model
CoolSnapPro CCD; Media Cybernetics) and ImageProPlus, or were pro-
cessed for immunocytochemistry as described above in Immunocytochem-
istry. For random migration assays, glass coverslips were fitted with silicone
grease onto the underside of 35-mm tissue culture dishes that had been
bored through with a heated metal cylinder. The inner glass surface was
coated with ECM proteins as described above in Immunocytochemistry,
and 3   10
4 cells were plated into each dish for 1 h. Cells were placed in
an open chamber with atmospheric and temperature controls (Schwartz,
1993) and viewed on a phase-contrast microscope (model IX70; Olympus).
Images were photographed and processed using ImageProPlus software.
Online supplemental materials
Fig. S1 shows  4(S988A) and  4 COOH-terminal paxillin fusion do not
perturb  4 integrin–dependent adhesion in CHO cells. Fig. S2 shows that
paxillin colocalizes with nonphosphorylated  4 at the lateral and trailing
edges but not with phospho- 4 at the leading edge in wounded confluent
monolayers. CHO cells expressing  4wt (Video 1),  4(S988A) (Video 2), or
an  4-paxillin chimera (Video 3) were plated onto 2  g/ml CS-1 for 1 h,
and viewed by phase-contrast microscopy as above in random migration
assays for a total of 6 h at 37 C. Images were captured every 10 min, 1 min,
or 10 s, as indicated in the figure legends. Online supplemental material is
available at http://www.jcb.org/cgi/content/full/jcb.200304031/DC1.
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